posted
Huge accumulation since last run. NITE has unlimited supplies at .045 - ones it moves we could fly...
Posts: 1580 | From: World | Registered: Jul 2006
| IP: Logged |
posted
News out after hours !! Knew there was a reason for that volume !!
Martin Nutraceuticals is Pleased to Announce Agreement with Novolypharma in Spain
Friday , January 26, 2007 16:05ET
RENO, Nev., Jan 26, 2007 (BUSINESS WIRE) -- Martin Nutraceuticals Inc. (PINKSHEETS:MNCL) is pleased to announce it is now in the final stages of an agreement with Novolypharma, out of Madrid, Spain. The agreement will not only provide for the production of its flagship products, but will also allow Martin Nutraceuticals to acquire the distribution rights for various Novolypharma products.
Novolypharma is a nutraceutical laboratory with the most advanced level of technology currently available in the nutraceutical manufacturing field, allowing it to conform to FDA (Pharmaceutical) Standards. Novolypharma is majority owned by X Consul Group Company, is a very well respected conglomerate in the nutraceutical marketplace, which includes companies such as CIMA 27, Ydosis and Kapal Consulting.
X Consul Global Company maintains the rights for the worldwide licensing of Novolypharma products, which includes the CGY 25 plant extract that promotes prostate and sexual health substantiated by scientific research conducted by the Montpelier University of France and the University of Seoul of South Korea.
"We are very excited about finalizing this agreement with Novolypharma and X Consul Global," states Mr. Harvey Panesar, President of Martin Nutraceuticals Inc., "this is a great boost for our current products as well the products that are being developed. Not only will we be with a FDA approved laboratory, we will also have access to many of Novolypharma's products, allowing us to maintain our quality of products and expand our product line. Getting ready for our US launch of the Infomercial and the products, we felt strongly about aligning ourselves with a GMP and FDA approved lab, which is what Novolypharma provides us."
About Martin Nutraceuticals Inc.
Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.
Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.
Safe Harbor Statement
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.
SOURCE: Martin Nutraceuticals Inc.
Taylor Capitol, Inc. Investor Relations: Stephen Taylor, 973-351-3868 STEPHTAYL9*AOL.COM
Copyright Business Wire 2007
-------------------- " Cash is King " Posts: 1102 | From: NJ | Registered: Mar 2006
| IP: Logged |
posted
Somebody in the know was buying this afternoon. We are not privy to the inside info but, they can't hide the volume. Especially when its 10X the 10-day average !!
-------------------- " Cash is King " Posts: 1102 | From: NJ | Registered: Mar 2006
| IP: Logged |
MNCL -- Martin Nutraceuticals, Inc. Com ($0.001)(New)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
*********.com: Speak with other shareholders about: (OTCBB: DYMTF), (OTC: MNCL) and (OTCBB: RDNT) .
AUSTIN, TX, Jan 30, 2007 (M2 PRESSWIRE via COMTEX) -- A very interesting indicator to look for is where the money is flowing into. We have a filter that we watch every morning that shows us "Dollar Volume". Here are a few of these stocks: Dynamotive Energy Systems Corporation (OTCBB: DYMTF), Martin Nutraceuticals Inc. (OTC: MNCL) and RADNET, INC. (OTCBB: RDNT) .
Posts: 132 | From: SC | Registered: Apr 2006
| IP: Logged |
Martin Nutraceuticals Inc. Announces Projections for 2007
RENO, Nev.--(BUSINESS WIRE)--Martin Nutraceuticals Inc. (MNCL.PK) is pleased to announce it has completed its internal projections for 2007. The Company has been working diligently to complete the DRTV (Infomercial) campaign for Medical Crisis - Secrets Your Doctor Won't Share With You, which is scheduled to run its test market in the second quarter 2007. "It has been a very long and hard road but we feel the finish line is getting closer and closer," states Harvey Panesar, President of Martin Nutraceuticals Inc.
Based on the test market airing in the second quarter of 2007 the company is projecting mass volume sales for the DRTV campaign to begin in third quarter of 2007. Internal projections are forecasting DRTV revenues to be in excess of $8,000,000 USD for the third and fourth quarters of 2007. In conjunction with the DRTV campaign the company anticipates an increased growth in product sales, which should lead to combined sales in excess of $10,000,000 USD by the end of 2007.
"In light of the timing of the DRTV campaign the company is being very reserved as it pertains to its internal projections," states Harvey Panesar, President of Martin Nutraceuticals.
About Martin Nutraceuticals Inc.:
Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.
Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.
For more information on the company, please contact investor relations at (973) 351-3868.
Safe Harbor Statement
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.
Contact: Taylor Capitol, Inc. Investor Relations: Stephen Taylor, 973-351-3868 STEPHTAYL9*AOL.COM
-------------------------------------------------------------------------------- Source: Martin Nutraceuticals Inc.
-------------------- " Cash is King " Posts: 1102 | From: NJ | Registered: Mar 2006
| IP: Logged |
posted
mncl looks good its coming off of its low for the year ive been in this stock for a few days and i can see it going to .08 .09 in the next trading day
Posts: 36 | Registered: Sep 2005
| IP: Logged |
posted
Sheesh.. what's up with this? Saw it's shadow a day early and decide to sleep for 6 more weeks?
Posts: 132 | From: SC | Registered: Apr 2006
| IP: Logged |
Martin Nutraceuticals Inc. Provides Shareholder Update
Friday , February 02, 2007 16:05ET
RENO, Nev., Feb 02, 2007 (BUSINESS WIRE) -- Mr. Harvey Panesar, President of Martin Nutraceuticals Inc. (PINKSHEETS:MNCL) reports that "from a corporate perspective, 2006 was a very full and exciting year for Martin Nutraceuticals Inc. In 2006, Martin Nutraceuticals was able to complete several of its key corporate objectives, which included retail exposure, a television campaign to support retail activities in Eastern Canada, completion of Dr. Martin's new book and a Direct Response Television (DRTV) campaign."
In 2006, Martin Nutraceuticals Inc. (MNI) obtained numerous listings with several key retailers for its flagship products. These listings enabled MNI to build brand exposure and a retail presence while the company completed a television campaign geared for Quebec operations.
Steady sales for MNI's flagship products continue as the company shifted focus in the second half of 2006 to concentrate on the launch of Dr. Martin's new book, Medical Crisis - Secrets Your Doctor Won't Share With You. The company made a corporate decision to change its marketing strategies by focusing on completing a Direct Response Television (DRTV) campaign to launch the Medical Crisis book in North America. Management strongly feels that the successful airing of the DRTV for the Medical Crisis book will result in increased retail demand of the company's flagship products going into the U.S. market. "We believe that the success of the book will be a great introduction to the fantastic products of Martin Nutraceuticals," states Mr. Panesar. "If the public is reading the book, it will give them a far better insight into how our products will contribute to their overall health."
"The DRTV industry is a multi-billion dollar industry and we immediately added more credibility to what we are aiming to achieve by choosing a reputable firm like Opfer Communications to implement our DRTV campaign," continued Mr. Panesar. The company is hoping to run the test market for the DRTV campaign early in the second quarter of 2007. This will provide ratings and customer feedback for the company before the nationwide launch of the DRTV campaign in Q3 of 2007.
One other key area which the company has been focusing on is the back-end solutions for the DRTV campaign. The company is very close to completing negotiations with call-center service providers and fulfillment centers which are an integral part of any DRTV campaign.
Martin Nutraceuticals has been in the process of re-branding the online image of the company. "We realize that our online growth could possibly be a lucrative avenue and one that we are preparing to fully explore," states Mr. Panesar. "The online community does millions of dollars of purchases monthly and we fully intend to tap into this market."
About Martin Nutraceuticals Inc.
Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.
Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.
For more information on the company, please contact investor relations at (973) 351-3868.
Safe Harbor Statement
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.
SOURCE: Martin Nutraceuticals Inc.
Taylor Capitol, Inc. Investor Relations: Stephen Taylor, 973-351-3868 STEPHTAYL9*AOL.COM
Copyright Business Wire 2007
-------------------- " Cash is King " Posts: 1102 | From: NJ | Registered: Mar 2006
| IP: Logged |
posted
Got several e-mails over the weekend on MNCL. Someone must be doing a PR campaign for them. I don't normally like getting those emails but might move in the morning !!
-------------------- " Cash is King " Posts: 1102 | From: NJ | Registered: Mar 2006
| IP: Logged |
Martin Nutraceuticals Inc. Retains Christopher Morgan for Infomercial Fulfillment
Wednesday, February 07, 2007 16:05ET
RENO, Nev., Feb 07, 2007 (BUSINESS WIRE) -- Martin Nutraceuticals Inc. (PINKSHEETS:MNCL) is pleased to announce that it has selected and retained Christopher Morgan Fulfillment Services (CM) in Wisconsin to provide MNCL's complete fulfillment needs. Mr. Harvey Panesar, President of Martin Nutraceuticals, stated that "it gives me a great sense of confidence that we have a highly respected, quality firm like Christopher Morgan handling the fulfillment of our infomercial demand. We certainly expect the infomercial for our future best-selling book, Medical Crisis: Secrets your Doctor won't Share with You, will be an instant infomercial success. We anticipate demand for the book will be such that we will definitely need single a source fulfillment center such as a firm like Christopher Morgan. The Customer Response team at CM has proven to us that customers like Martin can depend on them to process customer orders promptly, accurately and efficiently on a cost-effective basis."
About Christopher Morgan Fulfillment Services
Since 1997, Christopher Morgan has provided the e-commerce, financial, catalog and direct response television (DRTV) industry with fulfillment, assembly, distribution, customer care and integrated e-commerce expertise. Multiple distribution resources allows Christopher Morgan to ship a variety of products to any location worldwide via distribution partners UPS, FedEx, USPS and a variety of reliable common carriers. We offer live inventory status updates, order confirmation and tracking, return processing and other custom services.
Christopher Morgan works with strategic partners such as West Teleservices, Convergys, UPS, Fedex and USPS to service many clients with household names such as Travellers Insurance and Canella Response Television. CM is also a member of the Electronic Retailing Association and the Direct Marketing Association.
About Martin Nutraceuticals Inc.:
Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control.
Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days.
Safe Harbor Statement
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include, but are not limited to, fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.
SOURCE: Martin Nutraceuticals Inc.
Taylor Capitol, Inc. Stephen Taylor, 973-351-3868 (Investor Relations) STEPHTAYL9*AOL.COM
Copyright Business Wire 2007
-------------------- " Cash is King " Posts: 1102 | From: NJ | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Wink]](wink.gif)
![[Cool]](cool.gif)
